Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Total 13F shares
-
18,854,497
-
Share change
-
+285,407
-
Total reported value
-
$618,680,538
-
Put/Call ratio
-
134%
-
Price per share
-
$32.81
-
Number of holders
-
295
-
Value change
-
+$12,657,699
-
Number of buys
-
96
-
Number of sells
-
136
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q4 2023
As of 31 Dec 2023,
ARK ETF TR - GENOMIC REV ETF (ARKG) was held by
295 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,854,497 shares.
The largest 10 holders included
Main Management ETF Advisors, LLC, MORGAN STANLEY, BNP PARIBAS FINANCIAL MARKETS, UBS Group AG, STATE OF WISCONSIN INVESTMENT BOARD, LPL Financial LLC, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, Main Management LLC, and CITIGROUP INC.
This page lists
296
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.